Biochemistry
TCA Cycle and Oxidative Phosphorylation
~6 min read5 sections
The tricarboxylic acid (TCA) cycle and oxidative phosphorylation are the central energy-generating pathways of aerobic metabolism, collectively producing approximately 30-32 ATP molecules per glucose molecule. The TCA cycle (also called Krebs cycle or citric acid cycle) oxidizes acetyl-CoA to CO₂ while generating reduced electron carriers (NADH and FADH₂), which subsequently drive ATP synthesis through the electron transport chain (ETC) and chemiosmotic gradient in the inner mitochondrial membrane. Dysfunction in these pathways underlies multiple disease states including mitochondrial disorders, heart failure, sepsis, and ischemia-reperfusion injury, making understanding these mechanisms essential for clinical practice.
TCA Cycle Mechanisms
- Acetyl-CoA entry and condensation: Acetyl-CoA (2-carbon unit from pyruvate dehydrogenase, β-oxidation, or amino acid catabolism) condenses with oxaloacetate (4-carbon) via citrate synthase to form citrate (6-carbon); this is the committed, energy-requiring first step and primary regulatory point
- Oxidative decarboxylation steps: Isocitrate dehydrogenase and α-ketoglutarate dehydrogenase catalyze two critical oxidative decarboxylation reactions, each generating one NADH and releasing one CO₂; these are highly regulated by NAD⁺/NADH ratios and energy status (ATP/ADP, NADH/NAD⁺)
- Electron carrier generation: The cycle generates 3 NADH (worth ~7.5 ATP) and 1 FADH₂ (worth ~1.5 ATP) per acetyl-CoA, plus 1 GTP/ATP directly from succinyl-CoA synthetase (substrate-level phosphorylation)
- Anaplerotic reactions: Oxaloacetate (the cycle's starting material) must be continuously replenished; pyruvate carboxylase catalyzes the critical anaplerotic reaction converting pyruvate → oxaloacetate, and this is the only major route for net oxaloacetate synthesis
- Regulatory enzyme control: Isocitrate dehydrogenase and α-ketoglutarate dehydrogenase are inhibited by high NADH/NAD⁺ and ATP/ADP ratios (negative feedback), ensuring the cycle runs faster when energy is needed
Oxidative Phosphorylation Mechanisms
- Electron transport chain organization: Four protein complexes (I–IV) are embedded in the inner mitochondrial membrane; electrons flow from NADH (Complex I) or FADH₂ (Complex II) through sequential oxidation-reduction reactions, ultimately reducing O₂ to H₂O at Complex IV (cytochrome c oxidase)
- Proton gradient establishment: As electrons move through Complexes I, III, and IV, energy released pumps H⁺ ions from the matrix into the intermembrane space, creating an electrochemical gradient (proton-motive force) with both chemical (concentration) and electrical (membrane potential) components
- ATP synthase mechanism: ATP synthase (Complex V) harnesses the proton gradient; as H⁺ flows back into the matrix through the ATP synthase channel, conformational changes in the F1 subunit phosphorylate ADP + Pi → ATP; approximately 3-4 protons are required per ATP synthesized
- Oxygen as final electron acceptor: Molecular oxygen serves as the terminal electron acceptor; without O₂, the entire ETC halts because NADH and FADH₂ cannot be reoxidized to NAD⁺ and FAD, causing collapse of the TCA cycle and anaerobic metabolism with lactate accumulation
- Coupling and uncoupling: In normal conditions, oxidative phosphorylation is tightly coupled to electron transport (proton pumping and ATP synthesis are linked). Uncoupling proteins (UCPs, especially UCP1 in brown adipose tissue) allow H⁺ to pass through the membrane without driving ATP synthesis, dissipating energy as heat (thermogenesis)
Normal Physiology (Foundation for Pathology)
- The healthy state involves continuous, coordinated TCA cycle turnover and oxidative phosphorylation in all aerobic tissues, with the brain, heart, and kidney being most dependent on this pathway; tissues achieve steady-state ATP concentrations despite constant ATP consumption
Clinical Scenarios from TCA/Oxidative Phosphorylation Dysfunction
- Acute tissue hypoxia/ischemia (e.g., myocardial infarction, stroke, septic shock): Tissue hypoxia blocks Complex IV function, causing immediate cessation of the ETC and TCA cycle; tissues shift to anaerobic glycolysis, producing lactate and causing lactic acidosis; patients develop shock, altered mental status, arrhythmias, and organ failure if perfusion is not rapidly restored
- Mitochondrial diseases (genetic mutations in TCA enzymes, ETC complexes, or mitochondrial DNA): Present with multisystem involvement affecting high-energy-demand tissues; classic presentations include MELAS (mitochondrial encephalomyopathy, lactic acidosis, stroke-like episodes), MERRF (myoclonic epilepsy with ragged-red fibers), Leigh syndrome (progressive neurodegeneration with brainstem/basal ganglia involvement), and maternal inheritance pattern; patients have unexplained lactic acidosis and exercise intolerance
- Cyanide poisoning: Cyanide binds to the Fe³⁺ in cytochrome c oxidase (Complex IV), irreversibly blocking electron transport and halting all aerobic ATP production within minutes; patients present with rapid onset of cardiovascular collapse, loss of consciousness, and death despite adequate tissue oxygen (histotoxic hypoxia)
- Carbon monoxide poisoning: CO competes with O₂ for binding to Complex IV, functionally reducing oxygen utilization; causes acute hypoxia and can lead to delayed neuropsychiatric sequelae weeks later
- Thiamine (vitamin B1) deficiency: Thiamine pyrophosphate is a cofactor for pyruvate dehydrogenase and α-ketoglutarate dehydrogenase; deficiency impairs both entry into the TCA cycle and cycle progression, causing Wernicke encephalopathy (acute: ophthalmoplegia, ataxia, confusion) and Korsakoff syndrome (chronic: memory impairment, confabulation)
- Exercise intolerance with exertional symptoms: Patients with oxidative phosphorylation defects cannot meet the high ATP demand of exercise, presenting with muscle pain, fatigue, rhabdomyolysis risk, and post-exercise malaise
Clinical and Laboratory Approach
- Serum and urine lactate levels: Elevated lactate at rest or with minimal exertion suggests inadequate oxidative metabolism and reliance on anaerobic glycolysis; a serum lactate >4 mmol/L or elevated lactate-to-pyruvate ratio (>20) indicates impaired TCA cycle or ETC function; this is the most practical bedside marker of oxidative phosphorylation dysfunction
- Arterial blood gas (ABG) analysis: Look for metabolic acidosis with elevated anion gap in the setting of suspected mitochondrial disease or ischemia; normal PaO₂ in the presence of lactic acidosis suggests "histotoxic hypoxia" (tissue cannot use oxygen) rather than hypoxemic hypoxia
- Genetic testing and DNA analysis: Definitive diagnosis of mitochondrial disorders requires sequencing of nuclear genes encoding TCA/ETC proteins or direct mitochondrial DNA (mtDNA) sequencing; mtDNA mutations show maternal inheritance and heteroplasmy (mixture of wild-type and mutant alleles)
- Muscle biopsy with electron microscopy: Ragged-red fibers (subsarcolemmal mitochondrial accumulation staining with Gomori trichrome) suggest mitochondrial myopathy; electron microscopy may reveal abnormal cristae and paracrystalline inclusions
- Functional testing: Oxymetry and polarography can assess ETC enzyme activity in isolated mitochondria or tissue homogenates; cardiopulmonary stress testing may reveal abnormal lactate rise with minimal exertion in mitochondrial disease
- Brain and cardiac imaging: MRI may show stroke-like lesions not respecting vascular territories (MELAS), basal
The one association examiners test
- Succinate dehydrogenase (Complex II): the only enzyme in both the TCA cycle and the ETC, the only membrane-bound TCA enzyme, and the only step yielding FADH₂ rather than NADH — so it bypasses Complex I and yields less ATP per electron pair. Germline SDH mutations cause hereditary paraganglioma/pheochromocytoma (NCCN recommends germline testing in all patients with pheochromocytoma/paraganglioma).
- Other TCA enzymes as oncogenes: fumarate hydratase loss → hereditary leiomyomatosis and renal cell carcinoma; IDH1/IDH2 mutations → glioma and AML via oncometabolite 2-hydroxyglutarate.
Poisons, mapped to their complex
- Complex I: rotenone, MPP⁺ (parkinsonism). Complex III: antimycin A. Complex IV: cyanide, carbon monoxide, azide, hydrogen sulfide. Complex V: oligomycin. Uncouplers: 2,4-dinitrophenol, thermogenin/UCP1, salicylate overdose.
- Uncoupler physiology is the classic distractor: uncoupling increases O₂ consumption and heat while decreasing ATP yield. Do not pick "decreased oxygen consumption."
- Oligomycin vs. uncoupler: blocking ATP synthase raises the proton gradient and stops electron flow (respiratory control); an uncoupler collapses the gradient and accelerates it.
Single best next step
- Suspected cyanide toxicity (smoke inhalation, sodium nitroprusside infusion, near-normal PaO₂ with severe lactic acidosis and narrowed arteriovenous O₂ difference): hydroxocobalamin, per AHA/ACLS toxicology guidance; nitrite/thiosulfate kits are alternatives, and nitrites are avoided when concurrent CO poisoning is likely.
- Suspected CO poisoning: high-flow 100% oxygen immediately, with hyperbaric oxygen considered for severe or neurologic cases (ACEP clinical policy; Undersea and Hyperbaric Medical Society). Pulse oximetry reads falsely normal — order co-oximetry/carboxyhemoglobin.
- Suspected Wernicke encephalopathy: give thiamine before or with glucose, since glucose loading without thiamine can precipitate decompensation.
Cofactor and yield pearls
- "Tender Loving Care For Nancy": pyruvate dehydrogenase and α-ketoglutarate dehydrogenase share five cofactors — thiamine (B1), lipoic acid, CoA (B5), FAD (B2), NAD⁺ (B3). Arsenite inhibits lipoic acid, hitting both enzymes.
- 30 vs. 32 ATP per glucose: reflects which cytoplasmic NADH shuttle is used — glycerol-3-phosphate (muscle, yields FADH₂) versus malate–aspartate (liver/heart, yields NADH).